Acute administration of phencyclidine induces tonic activation of medial prefrontal cortex neurons in freely moving rats

Neuroscience

Volumn 114, Issue 3, 2002, Pages 769-779

  Suzuki, Y ^a   Jodo, E ^a   Takeuchi, S ^a   Niwa, S ^a   Kayama, Y ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Electrophysiology; Phencyclidine; Prelimbic cortex; Unit recording

Indexed keywords

PHENCYCLIDINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; GENERAL ANESTHESIA; MALE; MICROIONTOPHORESIS; MOVEMENT (PHYSIOLOGY); NERVE CELL STIMULATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; ANIMALS; MALE; NEURONS; PHENCYCLIDINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0037063718     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00298-1     Document Type: Article

References (49)

1. Adams B., Moghaddam B. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J. Neurosci. 18:1998;5545-5554.
2. Aghajanian G.K., Marek G.J. Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res. Rev. 31:2000;302-312.
3. Baba A., Yamamoto T., Kawai N., Yamamoto H., Suzuki T., Moroji T. Behavioral effects of phencyclidine and its major metabolite, (trans)4-phenyl-4-(1-piperidinyl)cyclohexanol, in mice. Behav. Brain Res. 65:1994;75-81.
4. Bakker C.B., Amini F.B. Observations on the psychotomimetic effects of Sernyl. Comp. Psychiatry. 2:1961;269-280.
5. Balster, R.L., Wessinger, W.D., 1983. Central nervous system depressant effects of phencyclidine. In: Kamenka, J.M., Domino, E.F., Geneste, P. (Eds.), Phencyclidine and Related Arylcyclohexylamines: Present and Future Applications. NPP Books, Ann Arbor, MI, pp. 291-309.
6. Breier A., Malhotra A.K., Pinals D.A., Weisenfeld N.I., Pickar D. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am. J. Psychiatry. 154:1997;805-811.
7. Castellani S., Adams P.M. Effects of dopaminergic drugs on phencyclidine-induced behavior in the rat. Neuropharmacology. 20:1981;371-374.
8. Creese I., Iversen S.D. The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res. 83:1975;419-436.
9. Domino, E.F., Luby, E., 1981. Abnormal mental states induced by phencyclidine as a model of schizophrenia. In: Domino, E.F. (Eds.), PCP (Phencyclidine): Historical and Current Perspectives. NPP Books, Ann Arbor, MI, pp. 401-418.
10. Fibiger H.C., Fibiger H.P., Zis A.P. Attenuation of amphetamine-induced motor stimulation and streotypy by 6-hydroxydopamine in the rat. Br. J. Pharmacol. 47:1973;683-692.
11. 10 dopamine neurons in the rat. Neuropharmacology. 25:1986;241-248.
12. Giovannini M.G., Mutolo D., Bianchi L., Michelassi A., Pepeu G. NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: a microdialysis study. J. Neurosci. 14:1994;1358-1365.
13. Gorelova N., Yang C.R. The course of neural projection from the prefrontal cortex to the nucleus accumbens in the rat. Neuroscience. 76:1999;689-706.
14. Gratton A., Hoffer B.J., Freedman R. Electrophysiological effects of phencyclidine on the medial prefrontal cortex of the rat. Neuropharmacology. 26:1987;1275-1283.
15. Groenewegen H.J., Berendse H. Connections of the subthalamic nucleus with ventral striatopallidal parts of the basal ganglia in the rat. J. Comp. Neurol. 294:1990;607-622.
16. Groenewegen H.J., Berendsf H.W., Wolters J.G., Lohman A.H.M. The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala: evidence for a parallel organisation. Prog. Brain Res. 85:1990;95-118.
17. Haggerty G.C., Forney R.B., Johnson J.M. The effect of a single administration of phencyclidine on behavior in the rat over a 21-day period. Toxicol. Appl. Pharmacol. 75:1984;444-453.
18. Hertel P., Mathe J.M., NomiKos G.G., Mathe A.A., Svensson T.H. Effects of D-amphetamine and phencyclide on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat. Behav. Brain Res. 22:1996;103-114.
19. Hori T., Suzuki T., Baba A., Abe S., Yamamoto T., Moroji T., Shiraishi H. Effects of phencyclidine metabolites on serotonin uptake in rat brain. Neurosci. Lett. 209:1996;153-156.
20. Itil T., Keskiner A., Kiremicti N., Holden J.M.C. Effect of phencyclidine in chronic schizophrenia. Can. Psychiatr. Assoc. J. 12:1967;209-212.
21. Jackson M.E., Moghaddam B. Amygdala regulation of nucleus accumbens dopamine output is governed by the prefrontal cortex. J. Neurosci. 21:2001;676-681.
22. Javitt D.C., Zukkin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 148:1991;1301-1308.
23. Jay T.M., Glowinski J., Thierry A.M. Inhibition of hippocampo-prefrontal cortex excitatory responses by the mesocortical DA system. NeuroReport. 6:1995;1845-1848.
24. Jay T.M., Thierry A.M., Wiklund L., Glowinski J. Excitatory amino acid pathway from the hippocampus to the prefrontal cortex: contribution of AMPA receptor in hippocampo-prefrontal cortex transmission. Eur. J. Neurosci. 4:1992;1285-1295.
25. Jay T.M., Witter M.P. Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of phaseolus vulgaris-leucoagglutinin. J. Comp. Neurol. 313:1991;574-586.
26. Jentsch J.D., Dazzi L., Chhatwal J.P., Verrico C.D., Roth R.H. Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats. Neurosci. Lett. 258:1998;175-178.
27. Jodo E., Chiang C., Aston-Jones G. Potent excitatory influences of prefrontal cortex activity on noradrenergic locus coeruleus neurons. Neuroscience. 83:1998;63-79.
28. Karreman M., Moghaddam B. The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area. J. Neurosci. 66:1996;589-598.
29. Kelly A., Domesick V., Mauta W. The amygdalostriatal projection in the rat: an anatomical study by anterograde and retrograde tracing methods. Neuroscience. 7:1982;615-630.
30. Kelly P.H., Seviour P.W., Iversen S.D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens and the corpus striatum. Brain Res. 94:1975;507-522.
31. Krettek J.E., Price J.L. The cortical projections of the mediodorsal nucleus and adjacent thalamic nuclei in the rat. J. Comp. Neurol. 171:1977;157-192.
32. Krystal J., Karper L., Bennett A., Abi-Saab D., Souza C., Abi-Dargham A., Charney D. Modulating ketamine-induced thought disorder with lorazepam and haloperidol in humans. Schizophr. Res. 15:1995;156.
33. Luby E.D., Cohen B.D., Rosenbaum G., Gottlieb J.S., Kelley R. Study of a new schizophrenomimetic drug - Sernyl. Am. Med. Assoc. Arch. Neurol. Psychiatry. 81:1959;363-369.
34. Luiten P.G.M., Gaykema R.P.A., Traber J., Spencer D.G. Jr. Cortical projection patterns of magnocellular basal nucleus subdivision as revealed by anterogradely transported Phaseolus vulgaris leucoagglutinin. Brain Res. 413:1987;229-250.
35. Mednikova Y., Loseva E.V., Karnup S.V., Zhadin M.N. Responses of cortical neurons to microiontophoretic application of acetylcholine to their dendrites. Neurosci. Behav. Physiol. 28:1998;107-115.
36. Moghaddam B., Adams B., Verma A., Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 17:1997;2921-2927.
37. Moghaddam B., Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science. 281:1998;1349-1352.
38. Ogren S.O., Goldstein M. Phencyclidine and dizociloine-induced hyperlocomotion are differentially mediated. Neuropsychopharmacology. 11:1994;167-177.
39. Paxinos, G., Watson, C., 1997. The Rat Brain in Stereotaxic Coordinates. Academic Press, London.
40. Rose J.E., Woolsey C.N. Structures and relation of limbic cortex and anterior thalamic nuclei in rabbit and cat. J. Comp. Neurol. 89:1948;279-347.
41. Rye D.B., Wainer B.H., Mesulam M.-M., Mufson E.J., Saper C.B. Cortical projections arising from the basal forebrain: a study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase. Neuroscience. 13:1984;627-643.
42. Satoh K., Fibiger H.C. Cholinergic neurons of the laterodorsal tegmental nucleus: efferent and afferent connections. J. Comp. Neurol. 253:1986;277-302.
43. Taber M., Fibiger H. Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors. J. Neurosci. 15:1995;3896-3904.
44. Verma A., Moghaddam B. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J. Neurosci. 16:1996;373-379.
45. White P.F., Way W.L., Trevor A.J. Ketamine - its pharmacology and therapeutic uses. Anesthesiology. 56:1982;119-136.
46. Yang C.R., Mogenson G.J. Dopaminergic modulation of cholinergic responses in rat medial prefrontal cortex: an electrophysiological study. Brain Res. 524:1990;271-281.
47. Yonezawa Y., Kuroki T., Kawahara T., Tashiro N., Uchimura H. Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex. Eur. J. Pharmacol. 341:1998;45-56.
48. You Z., Tzschentke T., Brodin E., Wise R. Electrical stimulation of the prefrontal cortex increases cholecystokinin glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats. J. Neurosci. 18:1998;6492-6500.
49. Zocchi A., Pert A. Alterations in striatal acetylcholine overflow by cocaine, morphine, and MK-801: relationship to locomotor output. Psychopharmacology. 115:1994;297-304.